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Summary 
The present study was designed to test the effect of bacterial endotoxin on penetration of viruses 
into the central nervous system (CNS). As a model we used two neurovirulent viruses that lack 
neuroinvasive capacity: West Nile virus-25 (WN-25) and neuroadapted  Sindbis virus  (SVN). 
Administration of lipopolysaccharide (LPS, 100/zg/mouse) to CD-1 mice, followed by WN-25 
inoculation resulted in 83% encephalitis and death, compared with <5% in controls. The results 
in SVN-inoculated  CD-1 mice were quite similar. LPS-treated  mice suffered  62% mortality compared 
with 6% in the nontreated group.  No changes in viral neuroinvasiveness were demonstrated 
in viruses isolated from brains of encephalitic mice, suggesting  that neuroinvasion is not due 
to a selection process for an invasive variant, but to direct penetration of the viruses through 
the blood-brain barrier (BBB). LPS did not induce WN-25 encephalitis  in LPS-insensitive  C3H/HeJ 
mice, compared with 100% neuroinvasion in C3H/HeB mice. Induction of neuroinvasion could 
be transferred to C3H/HeJ mice by transfusion with serum obtained from LPS-treated, LPS- 
responsive mice. Passive immunization of CD-1 mice with anti-mTNF antibodies before LPS 
administration did not prevent LPS-induced WN-25 encephalitis. Furthermore, neutralization 
of tumor necrosis factor activity in the serum of LPS-treated mice did not abolish its activity, 
and transfusion-associated encephalitis was observed after the administration  of the neutralized 
serum with WN-25. 
We suggest  that LPS can contribute to virus penetration from the blood into the CNS,  a 
process which turns a mild viral infection into a severe lethal encephalitis. This effect is mediated 
by soluble factors, and is probably achieved by injury to cerebral microvascular endothelium and 
modulation of BBB permeability. 
N 
'euroinvasiveness (ability to penetrate the central nervous 
system [CNS] 1) and neurovirulence  (ability to estab- 
lish a lethal infection within the CNS) are the crucial ele- 
ments that determine the capacity of a virus to cause enceph- 
alitis (1, 2). The major routes for virus spread into the brain 
are through nerves or via the bloodstream. Arboviruses, which 
are the most common known cause of encephalitis world- 
wide (3, 4), usually spread hematogenously. The blood-brain 
barrier  (BBB), ultrastructurally localized  at  the  cerebral 
microvascular endothelium, presents a major obstacle to neu- 
roinvasion from the blood (1,  2,  5). 
The mode and specificity of viral entry through the BBB 
into the CNS remains obscure. Factors other than inherent 
l Abbreviations  used in this paper: BBB, blood-brain  barrier;  CNS, central 
nervous  system; DS, donors' serum;  SVN, neuroadapted  Sindbis virus; 
WN-25, West Nile virus-25. 
genetic viral traits (1, 6-8) can influence neuroinvasion and 
allow entrance of noninvasive viruses into the CNS. Among 
such factors are modulation of BBB permeability by hyperoso- 
motic agents, hypercarbia,  hypothermia, and mechanical  breach 
(9-12). 
Modulation of BBB permeability was also found in ex- 
perimental bacterial meningitis.  Functional  and ultrastruc- 
tural changes of the BBB were revealed in animals challenged 
with live bacteria or with bacterial LPS (13, 14). 
The present experiments  were designed to test whether 
systemic administration  of LPS will lead to viral neuroinva- 
sion in a mouse model. To examine our hypothesis, that in- 
creased permeability of the BBB facilitates viral neuroinva- 
sion, we used two neurovirulent but noninvasive viruses, a 
flavivirus, West Nile virus-25 (WN-25) (15, 16) and an al- 
phavirus, neuroadapted  Sindbis virus (SVN)  (12, 17). 
The results presented herein dearly demonstrate that LPS 
is very effective in the induction of viral encephalitis by these 
otherwise noninvasive viruses. 
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Mice.  Female CD-1 mice were obtained from Charles River 
(London, UK), and C3H/HeB and C3H/HeJ mice were obtained 
from The Jackson Laboratories (Bar Harbor, ME). The mice used 
were aged 4-5 wk-old. In all experiments, mice of the same age 
and batch were used. 
Viruses.  The isohtion of WN-25 has been described previously 
(15, 16). Briefly, wild-type WNV was passed in Aedes aegypti cul- 
tures. At passage 25, the virus was plaque purified and kept in stock. 
Mice were inoculated intravenously with 0.2 ml containing 2  x 
10  s PFU.  Virus dilutions  were performed using PBS containing 
2%  FCS. 
The isolation of SVN has been described previously (12,  17). 
Briefly,  a nonvirulent strain of Sindbis  virus was passed by con- 
secutive intracerebral injections in suckling mice. A new passage 
variant was isolated at the 15th passage and was lethal to weanling 
mice when  injected  intracerebrally,  but  not  when  injected  in- 
traperitoneally. Mice were inoculated intravenously with 0.2 ml 
containing 1.5  x  10  s PFU. Virus dilutions were performed as for 
WN-25. 
LPS Challenge.  Mice were injected intraperitoneally with LPS 
(055/B5; Difco Laboratories,  Inc., Detroit, MI) diluted in pyrogen- 
free saline followed by virus injection into the tail vein. Mice were 
observed for mortality for 14 d. To determine changes in viral neu- 
roinvasive capacities, dying mice were killed and virus was isolated. 
The technique used for isolation of virus from brain tissue is de- 
scribed elsewhere (16). The isolated virus was tested for neuroinva- 
sion by peripheral inoculation of naive weanling CD-1 mice. 
Transfusion with Sera from LPS-treated Mice.  Blood was drawn 
from LPS-treated (100 pg/mouse) mice into serum separator tubes 
(Becton Dickinson & Co., Mountain View,  CA) and the serum 
was pooled (donors' serum [DS]).  DS was used fresh, after heat 
inactivation (56~  30 min) or stored at  -  70~  until further pro- 
cessing.  WN-25 was diluted in serum to 106 PFU/ml, and 0.2 ml 
were injected intravenously to naive mice. 
Blocking of TNF Effects.  To block TNF-mediated phenomena 
that are induced by LPS, we passively immunized mice against mu- 
fine TNFa.  Mice were injected intraperitoneally with  5  x  104 
neutralizing units of antimurine TNF antibodies (1@ U/ml, Gen- 
zyme Corp.,  Boston,  MA) 4  h before challenge. 
To block the effect of TNF in transfusion-associated encepha- 
litis, DS was mixed 10:1 with rabbit anti-TNF antibodies, and in- 
cubated for 60 min at 37~  Virus dilutions were then done, and 
the virus-containing solution was injected as described above. 
TNF bioactivity in the serum was assayed using A-9 cells. Briefly, 
3  x  104 cells (American Type Culture Collection, Rockvilh, MD) 
were seeded in wells of microtiter plates and allowed to adhere over- 
night. Wells were treated with serial dilutions of the sera followed 
by addition of cycloheximide (25/zg/ml). After 8-10 h incubation, 
the wells were washed and the number of surviving cells was de- 
termined by uptake of neutral red. Standard curves of human recom- 
binant TNF were run on each plate. Results are weight equiva- 
lents of human TNF activity. 
Data Analysis.  Differences in mortality were assessed using the 
two-tailed Fisher's exact test. 
Results 
LPS-inducedEncephalitis.  The experiments summarized in 
Table 1 were done to determine whether LPS affects WN-25 
neuroinvasion. CD-1 mice were injected intraperitoneaUy with 
various nonlethal doses of LPS, 2 h before WN-25 inocula- 
Table  1.  Dose Response of Mortality from  WN-25 Encephalitis 
after LPS Treatment 
LPS dose (/~g/mouse)  Dead/total  Percent 
0  1/16  6 
1  1/16  6 
5  2/16  12 
10  10/20  50* 
25  9/16  56* 
50  14/16  87.5"~ 
75  13/16  81"t 
100  18/20  90** 
200  15/16  94** 
CD-1 mice were injected intrapedtoneaUy with LPS (diluted in pyrogen- 
free saline to indicated doses), followed 2-h-later by intravenous inocula- 
tion with WN-25 virus (2  x  10  s PFU/0.2 ml). Mortality was observed 
on days 7-9.  No additional mortality  was observed until  21  d after 
inoculation. 
* P g0.01 vs. no LPS. 
* P g0.01 vs.  10/zg LPS. 
tion.  Death was recorded in 50%  of the mice treated with 
a 10-/zg dose of LPS and in 80% of those treated with a 100-/zg 
dose. Death occurred on days 7-9 after inoculation. The mean 
time of death was similar in groups injected with different 
LPS doses. 
Choosing  100/zg  as an effective neuroinvasion-inducing 
dose (10LDs0),  we investigated the significance of different 
schedules of virus inoculation  on mortality.  Inoculation of 
virus immediately after LPS or 24 h later resulted in a similar 
mortality rate. Inoculation with WN-25 48 h  after LPS in- 
jection  caused  death  in  five of the  eight  animals  injected 
(62.5%). The mortality of mice inoculated at 72 h after LPS 
was not  different from that of mice not  treated with LPS. 
The viral inoculum used in those experiments was chosen 
after previous studies that examined WN-25  neuroinvasion 
(16).  When  the  inoculum  was reduced,  it  was found  that 
Table  2.  Relation between WN-25 Dose and LPS-induced 
Encephalitis 
Infecting dose (PFU/mouse)  Dead/total  Percent 
2  x  106  6/7  86 
2  x  10  s  7/8  88 
2  x  104  4/7  57 
2  x  103  1/6  17 
2  x  10  ~  0/6  0 
CD-1 mice were inoculated intravenously with WN-25 at indicated doses 
2 h after administration of LPS (100/~g/mouse). Mortality was recorded 
on days 7-9. No mortality was observed thereafter. 
708  Lipopolysaccharides Induce Viral Neuroinvasion LPS neuroinvasion-inducing  activity is dependent upon the 
infecting dose (table  2).  LPS was still  effective when the 
WN-25 dose was reduced to 2  x  104 PFU per mouse, but 
not at lower WN-25 doses. Thus, an inoculum of 2  x  10  s 
was used in successive studies. 
To rule out the possibility that LPS-induced  encephalitis 
is unique for WN-25 virus,  the experiments were repeated 
with SVN. Again,  mortality was observed on days 7-9 in 
the LPS-treated  mice. Death rate was 62.5% with only 6% 
mortality in the SVN-infected,  nontreated mice (Fig.  1). 
To prove the specificity of the LPS-induced neuroinvasion 
phenomenon, we studied this  experimental  model in LPS- 
insensitive mice. Nontreated C3H/HeJ mice reacted the same 
as CD-1 and C3H/HeB mice to intravenous and intracerebral 
WN-25 challenge. When the three strains were treated with 
LPS followed by WN-25 inoculation, the mortality rate in 
the C3H/HeJ mice was  12.5%  compared with  100%  in 
C3H/HeB mice and  83% in CD-1 mice (Table 3). 
Viral Neuroinvasive Capacity.  Neuroinvasion  could be the 
consequence of the LPS-induced selection process that results 
in selection of a neuroinvasive strain. To eliminate this possi- 
bility, we examined the virus isolated from brains of six mice 
with LPS-induced encephalitis. Naive CD-1 mice were inoc- 
ulated intraperitoneaUy or intracerebrally with that virus. No 
mortality was observed in all mice injected intraperitoneally 
with 2  x  10  s PFU, whereas 100%  mortality was observed 
in mice injected intracerebrally  with 10 PFU. The ratio be- 
tween  titers  (PFU/ml,  intracerebral  LDs0, intraperitoneal 
LDs0) was similar to that of the original  WN-25 (16), indi- 
cating that no changes occurred in the neuroinvasive proper- 
ties of the virus. The same findings were demonstrated with 
the virus recovered from the brains of SVN-encephalitic mice. 
Transfusion Studies.  These experiments  were planned  to 
determine whether LPS-induced  neuroinvasion  is mediated 
by soluble factors. The DS obtained from CD-1 mice (donors) 
after LPS challenge  (100/~g/mouse) was mixed with virus 
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Figure 1.  Induction of SVN encephalitis and mortality by LPS. CD-1 
mice were injected intraperitoneally  with LPS (100/~g/mouse) or pyrogen- 
free saline, followed 2 h later  with SVN (1.5  x  10  s PFU/0.2 ml i.v.). 
Mice inoculated intracerebrally  were given 10 PFU in 0.03 mi PBS. No 
additional  mortality was observed until 21 d after inoculation.  P g0.01 
when compared  with the SVN/saline or the LPS only groups. 
Table  3.  Mortality  from  WN-25 Encepkalitis in LPS-treated 
CD-1, C3I'I/HeB, and C3H/HeJ Mice 
Treatment  Mouse strain  Dead/total  Percent 
LPS 100/~g  CD-1  0/20  0 
C3H/HeB  0/10  0 
C3H/HeJ  O/8  0 
WN-25  intravenous  CD-1  2/45  4 
C3H/HeB  0/8  0 
C3H/HeJ  0/8  0 
WN-25 intracerebral  CD-1  20/20  100 
C3H/HeB  10/10  100 
C3H/HeJ  8/8  100 
LPS  +  WN-25  CD-1  88/106  83* 
(intravenous)  C3H/HeB  20/20  100 
C3H/HeJ  5/40  12.5' 
LPS (100/~g/mouse) or pyrogen-free saline was injected  intraperitone- 
ally 2 h before inoculation  with WN-25  (2  x  10  s PFU in 0.2 ml of 
PBS with 2% FCS, intravenous) To check viral neurovirulence mice were 
injected intracerebrally with 10 PFU in 0.03 ml PBS. Mice were observed 
for mortality for 14 d. 
* P  g0.01  compared  with control. 
* P  g0.01  compared  with C3H/HeB mice. 
and  injected  to naive mice.  LPS levels were assayed in the 
DS using the limulus lysate test.  In three samples that were 
assayed at 2 h post-LPS, levels were below 100 ng/ml. Thus, 
the LPS dose injected in DS could not exceed 20 ng/mouse. 
To abolish this residual LPS activity, which is far below the 
minimal  effective dose, C3H/HeJ mice were selected to be 
used as recipients.  Injection of DS (obtained at 90-120 rain 
after LPS) mixed with WN-25 induced encephalitis in 75% 
of the C3H/HeJ mice and in 78.8% of CD-1 mice. No effect 
was observed with sera obtained from LPS-injected C3H/HeJ 
mice.  When DS obtained at 6 h after challenge  was used, 
the effect was diminished  to 14% encephalitis  rate. DS ob- 
tained  at 24 h after challenge was not at all effective. Heat 
inactivation  of DS almost completely abolished encephalitis 
induction, whereas storage of the serum at  -70~  did not 
affect its activity (Table 4). 
Neutralization of TNF Effects.  TNF is a major mediator 
of LPS pathophysiologic  sequela which is found in high levels 
1-2 h  after  LPS administration.  We investigated  whether 
blocking the LPS-induced  TNF response  would effect the 
induction of WN-25 encephalitis.  TNF levels in the serum 
were assayed in control CD-1 mice 90 min after LPS (100 
/~g/mouse)  and were found to be 9.3  _  2.8 ng/ml  (n  = 
8,  mean  _+  SEM).  CD-1 mice were passively immunized 
against TNF using rabbit polyclonal antimurine TNFoe an- 
tibodies.  No TNF activity was detected in the sera of im- 
munized mice at  90 min after LPS. Passive immunization 
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of WN-25 Encephalitis 
Challenge  Recipient  mice  Dead/total  Percent 
DS  C3H/HeJ  6/8  75 
DS  CD-1  41/52  79 
DS  C3H/HeB  7/8  87.5 
DS (from  C3H/HeJ)  CD-1  1/9  11 
Control sera  CD-1  0/8  0 
C3H/HeB  0/8  0 
C3H/HeJ  0/8  0 
DS (+ 56~  *)  CD-1  0/8  0 
DS ( - 70~  *)  CD-1  7/8  87.5 
DS (6 h s)  CD-1  2/14  14 
DS (24 h tl)  CD-1  0/14  0 
DS were obtained from CD-1 mice (unless indicated  otherwise)  90-120 
min (unless indicated otherwise)  after LPS (100 #g/mouse). WN-25 vi- 
res was diluted twofold in DS and 0.2 ml were injected intravenously. 
Control mice were injected with WN-25 diluted in serum of naive CD-1 
mice. 
* DS incubated  in 56~  for 1 h before  dilution with virus. 
* DS stored in  -70~  until use. 
S DS drawn 6 h  after  LPS challenge. 
tl DS drawn  24 h after  LPS challenge. 
resulted in a mild delay in the time of death (statistically non- 
significant),  but no difference was observed in LPS-induced 
WN-25  encephalitis  and death rates. 
To assess TNF involvement in transfusion-associated en- 
cephalitis, DS was incubated with anti-TNF antibodies. No 
TNF activity was detected by bioassay in incubated DS, but 
it still effectively induced WN-25 neuroinvasion and enceph- 
alitis  in naive CD-1  and  C3H/HeJ mice. 
Discussion 
The present experiments demonstrate that systemic adminis- 
tration  of LPS to mice can induce viral neuroinvasion  and 
encephalitis. 
As a model we used two viruses that  lack neuroinvasive 
capacities,  but kill mice when injected intracerebrally.  Neu- 
roinvasion is easily evaluated in these models, as brain penetra- 
tion by <10 PFU of either one of these viruses results in the 
development of severe lethal encephalitis 7-9 d after inocula- 
tion  (11). 
The ratio between asymptomatic infection and clinical dis- 
ease varies  for the different neurotropic viruses.  However, 
asymptomatic or mild infections are extremely common (3, 
4). The factors responsible for the progression of asymptom- 
atic or mild infections to life-threatening encephalitis are not 
defined. Our data suggest that infection with gram-negative 
bacteria may play a role in the determination  of the clinical 
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course of infection with a neurotropic virus. Such infection, 
either recent (48 h earlier in our study) or concurrent,  can 
turn a mild infection into a severe encephalitis.  Infections with 
gram-negative bacteria are extremely prevalent, especially in 
the young and in the elderly-the same age groups that are 
most commonly affected by viral encephalitis  (18). 
WN-25 virus can cause encephalitis in mice subjected to 
isolation or repeated cold stress (16). The virus that was iso- 
lated from brains of mice with such stress-induced encepha- 
litis was different to the virus injected, by virtue of a neu- 
roinvasive  capacity,  similar  to  that  of wild-type  WNV. 
Neuroinvasion was then  attributed  to immunosuppression 
with increased replication,  allowing back-mutation and se- 
lection of an invasive  strain.  That was not  the case in the 
present study. The virus that was isolated from brains of en- 
cephalitic mice was similar to the virus with which they were 
inoculated,  and it  did not demonstrate  any invasive  traits. 
Thus, it seems that LPS-induced neuroinvasion is due to al- 
tered host mechanisms,  rather  than  the result of a change 
in viral traits.  Heinz et al.  (19) studied the molecular basis 
of attenuation in flaviviruses,  and suggested that the loss of 
the neuroinvasive capacity is due to a defect in the domain 
B of the viral protein E. The ability of this protein to bind 
to a specific receptor was presumed to establish the neuroin- 
vasive capacity. We speculate that in our model, LPS made 
it possible to bypass the binding to receptor process, which 
is otherwise mandatory. Thus, considering the ability of LPS 
to increase the permeability of the BBB (13, 14), we suggest 
that  neuroinvasion  is  achieved by injury  to  the  BBB  and 
penetration  of viruses through  the breach. 
C3H/HeJ mice are resistent to LPS toxicity because of a 
defective immunologic response to LPS, which includes a de- 
fect in TNF production  (20, 21). LPS did not induce neu- 
roinvasion in these mice in contrast with the high rates  of 
neuroinvasion observed in CD-1 and C3H/HeB mice. The 
absence of  ~  " "  encephalms in LPS-treated C3H/HeJ mice indi- 
cates once again that the host response was the major deter- 
minant of neuroinvasion in our model. Encephalitis was ob- 
served after transfusion  of C3H/HeJ mice with serum obtained 
from LPS-sensitive mice challenged with LPS.  This  trans- 
fusion-associated neuroinvasion points to a soluble mediator 
or mediators, probably of lymphoid origin, that can indepen- 
dently induce neuroinvasion.  The lack of activity in heat- 
inactivated serum suggests proteins as these mediators. The 
lack of activity of DS obtained 6 h after LPS indicates a short 
mediators response. However, LPS is effective in inducing neu- 
roinvasion even if the virus is inoculated as late as 48 h. Thus, 
it seems that a short mediators response after LPS enable neu- 
roinvasion for a period over 48 h. 
TNF is a major mediator  of LPS pathophysiological se- 
quela, which is found in high levels in the serum at  1-2 h 
after LPS challenge and disappears at 5 h (22). Existing evi- 
dence implies that it is capable of increasing the permeability 
of microvascular endothelium throughout the body (23, 24), 
including that of the BBB (25). Based on these studies, we 
hypothesized that TNF is the mediator of LPS-induced neu- 
roinvasion.  However, this theory was negated since we showed 
that viral neuroinvasion was not prevented in LPS-challenged 
Neuroinvasion mice that were passively immunized against TNF. No con- 
clusions can yet be drawn on the contribution  of TNF re- 
sponse to neuroinvasion.  Our data indicate that it may not 
be an essential direct mediator of LPS-induced and transfusion- 
associated neuroinvasion. 
The pathophysiological sequela of LPS administration in- 
volves activation of the cells of the mononuclear phagocyte 
system with increased production and release of several medi- 
ators including Ibl.  IL-6, interferons,  histamine,  and TNF 
(21, 26, 27). Further experiments would evaluate the effects 
of these mediators  on neuroinvasion  and whether  they are 
involved in LPS-induced neuroinvasion. 
When WN-25 and the wild-type WNV were compared 
(28), it was found that  apart from different plaque sizes in 
Vero culture,  the only difference in biological activity was 
in their ability to replicate in macrophage cultures. Whereas 
adsorption to macrophages was similar for both viruses, repli- 
cation was some 100-fold-higher for the wild-type. Adsorp- 
tion of neurotropic viruses to macrophages, with and without 
amplification,  has been described with several other viruses 
(2, 9, 29, 30). Recently, it was shown that the cells of mice 
infected with dengue virus release  a cytokine that  induces 
a breakdown of the BBB (31). 
Based on these findings, we suggest that the difference be- 
tween invasive and nonneuroinvasive viruses could be found 
in the virus' ability to stimulate the host mechanism, enabling 
its penetration through the BBB. Furthermore, we may spec- 
ulate that macrophages and their products have a role in the 
pathogenesis of WNV encephalitis and in the determination 
of the neuroinvasive capacity. Additional studies are required 
to investigate the production of cytokines during infections 
by WNV and other neurotropic viruses, and to determine 
the involvement of cytokines in the pathogenesis of viral en- 
cephalitis. 
Neuroinvasion  of neurotropic viruses was considered to 
be effected by inherent  viral  traits  (1).  The present  study 
demonstrates that LPS is capable of turning a mild viral in- 
fection into lethal encephalitis by inducing viral invasion to 
the CNS. This effect is mediated by endogenous mediators 
and is probably achieved  by breaching  of the BBB, which 
enables viral penetration to the CNS. These findings add valu- 
able information to the understanding of the pathophysiology 
of viral encephalitis  and may have therapeutic implications 
for these hazardous  and lethal infections. 
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